Cargando…
Exploring circulating micro‐RNA in the neoadjuvant treatment of breast cancer
Breast cancer is the most frequently diagnosed malignancy amongst females worldwide. In recent years the management of this disease has transformed considerably, including the administration of chemotherapy in the neoadjuvant setting. Aside from increasing rates of breast conserving surgery and enab...
Autores principales: | Casey, Máire‐Caitlín, Sweeney, Karl J., Brown, James Andrew Lawrence, Kerin, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066681/ https://www.ncbi.nlm.nih.gov/pubmed/26756433 http://dx.doi.org/10.1002/ijc.29985 |
Ejemplares similares
-
Evolution of a research field—a micro (RNA) example
por: Casey, Máire-Caitlín, et al.
Publicado: (2015) -
Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer
por: McGuire, Andrew, et al.
Publicado: (2020) -
Evaluating the Role of Circulating MicroRNAs to Aid Therapeutic Decision Making for Neoadjuvant Chemotherapy in Breast Cancer: A Prospective, Multicenter Clinical Trial
por: Davey, Matthew G., et al.
Publicado: (2022) -
Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer
por: Davey, Matthew G., et al.
Publicado: (2023) -
Circulating microRNAs as potential new biomarkers for prostate cancer
por: Sita-Lumsden, A, et al.
Publicado: (2013)